Current Journal of Neurology

Volume 23, Issue 2
April 2024

Document Type : Original Article

Authors

• Mohammad Javad Gholamzadeh 1
 
• Etrat Hooshmandi   2
 
• Zahra Ghahramani 3
 
• Reza Fereidooni 4
 
• Alireza Rezvani 3
 
• Maryam Vasaghi-Gharamaleki 2
 
• Hossein Molavi-Vardanjani 5
 
• Sadegh Shirian 6
 
• Nima Fadakar 2
 
• Vahid Reza Ostovan 2
 
• Maryam Poursadeghfard  2
 
• Nahid Ashjazadeh 2
 
• Afshin Borhani-Haghighi   2

1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran MD-MPH Dual Degree Program, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

5 MD-MPH Dual Degree Program, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

6 Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran Shiraz Molecular Pathology Research Center, Daneshbod Pathology Lab, Shiraz Iran

Abstract

Abstract
Background: Several laboratory markers derived from a complete blood count (CBC) have been proposed as potential indicators for assessing the risk of cerebral venous thrombosis (CVT). However, limited and conflicting evidence exists regarding this association. This study aimed to evaluate the role of CBC parameters in CVT development and their link to disease characteristics.
Methods: This case-control study included patients diagnosed with CVT between March 2018 and March 2021. All participants with CVT were registered in the organized registry system at the Neurology Research Center of Shiraz University of Medical Sciences, Shiraz, Iran (CVT registry code: 9001013381). 
The control group consisted of age- and sex-matched individuals without systemic diseases. CBC results from the control group and the first recorded hospital CBC of the patient group were collected.
Results: The study included 295 patients with CVT [49 with idiopathic CVT (iCVT) and 246 with secondary CVT (sCVT)] and 341 healthy individuals. Among the CVT group, 72.54% were women. Patients with CVT had higher red cell distribution width (RDW) and lower red blood cell (RBC) count, hemoglobin (Hb) levels, and hematocrit compared to the non-CVT group. In iCVT cases, male gender, RBC count, Hb levels, and hematocrit were notably higher compared to sCVT cases. Logistic regression analysis showed that female gender, smoking, and higher hematocrit values were associated with increased probability of iCVT.
Conclusion: The study suggests that certain CBC parameters may serve as potential markers for assessing CVT risk and differentiating between iCVT and sCVT cases. Validation and further research are needed to explore the underlying mechanisms.

Keywords

• Cerebral Venous Thrombosis
 
• Complete Blood Count
 
• Red Blood Cell
 
• Erythrocyte Indices